Group I | Group II | Group III | Group IV | P value | |
---|---|---|---|---|---|
N = 607 | N = 574 | N = 663 | N = 706 | ||
<13.1% | 13.1 ≥ and <13.6% | 13.6% ≥ and <14.1% | ≥14.1% | ||
Aspirin | 601 (99.0) | 569 (99.1) | 658 (99.2) | 693 (98.2) | 0.21 |
Clopidogrel/Thienopiridines | 607 (100) | 572 (99.7) | 658 (99.2) | 699 (99.0) | 0.25 |
ACE-I/ARB | 585 (96.4) | 539 (93.9) | 622 (93.8) | 641 (90.8) | 0.0006 |
Beta-blockers | 581 (95.7) | 555 (96.7) | 630 (95.0) | 671 (95.0) | 0.44 |
Calcium channel blockers | 106 (17.5) | 82 (14.3) | 100 (15.1) | 112 (15.9) | 0.47 |
Diuretics | 203 (33.4) | 194 (33.8) | 229 (34.5) | 315 (44.6) | <0.0001 |
Nitrates | 121 (19.9) | 166 (28.9) | 223 (33.6) | 233 (33.0) | <0.0001 |
VKA | 23 (3.8) | 32 (5.6) | 47 (7.1) | 83 (11.8) | <0.0001 |